Silver Springs Aziyo Biologics laying off 12 percent of workforce
AZYODelisted Stock | USD 2.44 0.00 0.00% |
About 56% of Aziyo Biologics' investor base is looking to short. The analysis of current outlook of investing in Aziyo Biologics suggests that many traders are alarmed regarding Aziyo Biologics' prospects. Aziyo Biologics' investing sentiment overview a quick insight into current market opportunities from investing in Aziyo Biologics. Many technical investors use Aziyo Biologics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aziyo |
Aziyo Biologics co-founders are Chairman Kevin Rakin, left, and CEO Randy Mills.
Read at bizjournals.com
Aziyo Biologics Fundamental Analysis
We analyze Aziyo Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aziyo Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aziyo Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Aziyo Biologics is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Aziyo Biologics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aziyo Biologics stock to make a market-neutral strategy. Peer analysis of Aziyo Biologics could also be used in its relative valuation, which is a method of valuing Aziyo Biologics by comparing valuation metrics with similar companies.
Peers
Aziyo Biologics Related Equities
NVNO | EnVVeno Medical | 0.71 | ||||
SRDX | SurModics | 0.10 | ||||
OFIX | Orthofix Medical | 0.72 | ||||
ANIK | Anika Therapeutics | 0.98 | ||||
IRIX | IRIDEX | 1.15 | ||||
ELMD | Electromed | 1.47 | ||||
AXGN | Axogen | 1.73 | ||||
ESTA | Establishment Labs | 1.74 | ||||
AORT | Artivion | 1.93 | ||||
LNSR | LENSAR | 2.08 | ||||
AVNS | Avanos Medical | 2.55 | ||||
SSKN | STRATA Skin | 2.60 | ||||
SGHT | Sight Sciences | 3.76 | ||||
CVRX | CVRx | 4.25 | ||||
NXL | Nexalin Technology | 4.81 | ||||
AIMD | Ainos | 6.38 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Aziyo Stock
If you are still planning to invest in Aziyo Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aziyo Biologics' history and understand the potential risks before investing.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Valuation Check real value of public entities based on technical and fundamental data |